BECTON, DICKINSON AND COMPANY Most Important Performance Measures
The measures each proxy statement lists as most important for linking pay to performance (Item 402(v) tabular list), as tagged, newest proxy first.
- 2023-12-14: Measure Revenue*.
- 2023-12-14: Measure Adjusted EPS*.
- 2023-12-14: Measure Free cash flow*.
- 2023-12-14: Measure Operating margin*.
| Proxy filed | Measure |
|---|---|
| 2023-12-14 | Revenue* |
| 2023-12-14 | Adjusted EPS* |
| 2023-12-14 | Free cash flow* |
| 2023-12-14 | Operating margin* |
| 2023-12-14 | ROIC* |
| 2024-12-19 | Revenue* |
| 2024-12-19 | Adjusted EPS* |
| 2024-12-19 | Free cash flow* |
| 2024-12-19 | Operating margin* |
| 2024-12-19 | ROIC* |
| 2025-12-18 | Revenue* |
| 2025-12-18 | Adjusted EPS* |
| 2025-12-18 | Free cash flow* |
| 2025-12-18 | Operating margin* |
| 2025-12-18 | ROIC* |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |